Q3 2023 · 13F-HR
Krensavage Asset Management, LLCholdings as filed
Filed 2023-11-15 · accession 0001609251-23-000005
$271,606
Reported value
12
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP | $45,450 | 16.7% | 201,222 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $41,496 | 15.3% | 1,899,151 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $41,245 | 15.2% | 160,480 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $38,890 | 14.3% | 47,256 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $25,379 | 9.34% | 906,060 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $25,292 | 9.31% | 291,319 | Common | SOLE |
| M8737E108 | — | TARO PHARMACEUTICAL INDUS | $24,162 | 8.90% | 640,735 | Common | SOLE |
| 29082K105 | EMBC | EMBECTA CORP | $17,531 | 6.45% | 1,164,876 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $8,211 | 3.02% | 735,103 | Common | SOLE |
| 269796108 | EGRX | EAGLE PHARMACEUTICALS INC | $1,777 | 0.65% | 112,666 | Common | SOLE |
| 921659108 | VNDA | VANDA PHARMACEUTICALS INC | $1,557 | 0.57% | 360,429 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $616 | 0.23% | 342,312 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.